Navigation Links
Nanoparticles can track cells deep within living organisms

mors. Under an MRI scan, the presence of the labeled cells would reveal that the tumor was adding new blood vessels and therefore aggressively growing.

Adult stem cells are also under investigation in therapies that enhance new blood vessel growth to improve the blood supply to diabetic patients' limbs or to repair blood vessels after a heart attack or bypass surgery. Tracking nanoparticle-labeled cells used in such treatments by MRI imaging would allow physicians to monitor the treatment's success or failure.

The nanoparticles ?called "nano" because they measure only about 200 nanometers across, or 500 times smaller than the width of a human hair ?are made up largely of perfluorocarbon, a safe compound used in artificial blood. The fluorine atoms in the particles can be detected by tuning an MRI scanner to the unique signal frequency emitted by the perfluorocarbon compound used.

Since several perfluorocarbon compounds are available, different types of cells potentially could be labeled with different compounds, injected and then detected separately by tuning the MRI scanner to each one's individual frequency, says Wickline.

That makes the labeled cells potentially useful for vascular research as well. "Many kinds of cells are involved in the formation of new blood vessels," Partlow says. "Because we can create a separate MRI signature for different cells with these various types of unique nanoparticles, we could use them to better understand each cell type's role."

The nanoparticles are very compatible with living cells, according to the research findings. "The cells just take these particles in naturally ?no special sauces have to be added to make them tasty to these cells," says Wickline, also professor of medicine, of physics and of biomedical engineering and a Washington University heart specialist at Barnes-Jewish Hospital. "And then the cells just go about their business and do what they're supposed to do
'"/>

Source:Washington University School of Medicine


Page: 1 2 3

Related biology news :

1. DNA Molecules Used To Assemble Nanoparticles
2. Imaging Lymph Nodes with Nanoparticles
3. Probing The Promise And Perils Of Nanoparticles
4. Nanoparticles offer new hope for detection and treatment
5. Nanoparticles carry cancer-killing drugs into tumor cells
6. Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer
7. Nanoparticles for delivery of prostate cancer treatment
8. Cancer tip -- Nanoparticles can damage DNA, increase cancer risk
9. Protein offers way to stop microscopic parasites in their tracks
10. Stopping smallpox in its tracks: A new anti-viral approach
11. Findings have implications for tracking disease, drugs at the molecular level

Post Your Comments:
(Date:11/4/2009)...Call/ -- Quest Diagnostics Incorporated (NYSE: DG...sting, information and services, announced that fo...me from continuing operations rose to $192 million...r $0.81 per diluted share, for the third quarter o...d by a $0.03 per share charge associated with the ...
(Date:11/4/2009)...- GenVault Corporation, the leader in ambient temp..., medicine and identification, today announced tha...O, will be presenting at the BIOCOM Investor Confe...Jolla, CA. ,, During the presentation, Dr. Well...r with recent customer, technical and strategic de...
(Date:11/4/2009)... GenVault Corporation (Carlsbad, CA) today announc... Board of Directors. Dr. Brody, the Irwin Jacobs ...claimed physician-scientist and university leader....erved as president of The Johns Hopkins University...eering and the Institute of Medicine, and is renow...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Rice University researchers ask if biofuels will lead to a drink or drive 8827 1Rice University researchers ask if biofuels will lead to a drink or drive 8827 2Sinovac Completes Construction of H1N1 Virus Seed Bank 12626 1Sinovac Completes Construction of H1N1 Virus Seed Bank 12626 2Sinovac Completes Construction of H1N1 Virus Seed Bank 12626 3Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 1Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 2Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 3Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 4Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 5Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 6
...tudy led by Akiko Hata, PhD, of Tufts University S...rotein expressed in the heart, FHL2, inhibits the ...oth muscle cells (vSMCs), which line blood vessels...n diseases such as atherosclerosis or normal tissu...transition between a resting and proliferative sta...
... that affect blood pressure were recently identifi...ng 34,433 Europeans. The findings of the study, in..., are being presented today in the Web edition of ...or contributing cause of cardiovascular disorders....difficult to identify genes that affect blood pres...
...emical Society (ACS) Weekly PressPac from the Offi...r-reviewed journals and Chemical & Engineering Ne...American Chemical Society as the source for this i...s.org/portal/PublicWebSite/pressroom/presspacs/CTP...dvance toward producing biofuels without stressing...
Other Biology News:Comprehensive genetic study paves way for new blood-pressure medicines 2American Chemical Society's weekly PressPac -- May 6, 2009 2American Chemical Society's weekly PressPac -- May 6, 2009 3American Chemical Society's weekly PressPac -- May 6, 2009 4American Chemical Society's weekly PressPac -- May 6, 2009 5American Chemical Society's weekly PressPac -- May 6, 2009 6
(Date:11/6/2009)...Myriant Technologies LLC ("Myriant"), a privately-...able bio-chemicals, Uhde Corporation of America an... of the world,s leading engineering contractors (j...neering, procurement & construction (EPC) of M...newable feedstocks. The execution of this allianc...
(Date:11/6/2009)...- Intarcia Therapeutics, Inc. delivered two presen...ous delivery of exenatide) program for the treatme... Technology Meeting in San Francisco, CA: ,, (L.../SFTU126LOGO ) ,, Continuous Subcutaneous Del...ose, HbA1c and Reduces Weight in a 28-day Phase 1b...
(Date:11/5/2009)...-- DSM Pharmaceutical Products today announced tha...x, Saint Jean D,Illac, France, where DSM will be t...r for Galenix commercial products on a global basi...ess development opportunities co-marketing Galenix... of Galenix in drug product development and clinic...
(Date:11/5/2009)...stCall/ -- BioSpecifics Technologies Corp. (Nasdaq...first-in-class collagenase-based products, today a...er ended September 30, 2009. ,, "We were extre...A,s Arthritis Advisory Committee unanimously recom...(TM) for the treatment of Dupuytren,s disease, and...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
...r immune enhancement during cold & flu season, PU...utrition Reviews (Vol. 66(9):526-531) by Dr. Barry...nology at Drexel University, has shown,how AHCC im...ctious agents., The scientific review analyzed ou...of AHCC supplementation on immune response followi...
...pt. 24 Omeros Corporation, a,Seattle-based biopha...ment,of a $20 million debt facility with BlueCrest...llion term loan drawn by Omeros at closing and the...p to the remaining $15,million. Other terms were n...with increased financial flexibility,as we continu...
...nced Life Sciences,Holdings, Inc. (Nasdaq: ADLS )...rn Time on Wednesday, October 1, 2008 to provide a...nference Call Details, The conference call will b...bcast, visit the Investor Relations section of the...://www.advancedlifesciences.com . Alternatively,in...
Other Biology Technology:Research Shows How AHCC(R) May Help Fight Flu and Other Infectious Agents 2Omeros and BlueCrest Announce $20 Million Debt Facility 2Advanced Life Sciences to Host Conference Call to Update Investors on Progress of Corporate Initiatives on October 1, 2008 2
...igned for easy transformation of the budding yeast...sful transformation simply by mixing a plasmid DNA...o complicated steps, such as centrifugation or cel...ell suited for high-throughput transformation of a...
... help promote genomics-based research with S. aure... aureus ORFmer set that contains PCR primers to am...rain1. In addition, primer pairs are included to a...315 strains of S. aureus. The ORFmer set contains ...
...s own microplate stacker system, offers fast and r...ost devices:, , Ultra Evolution , SAFIRE monochrom...ctraFluor Plus , LS Series of Laser Scanners , Pow...ion and separation systems, Connect offers researc...
...e increases your lab productivity and allows you t... compliance. Move ahead beyond traditional paper-b... networked data system. *Instruments supported: ..., XP, PR, SR, PG-S, PG, SG, AT, MT, UMT, AB-S, PB-...
Biology Products: